Dexamethasone suppression test in borderline personality disorder—effects of posttraumatic stress disorder

Lange W, Wulff H, Berea C, Beblo T, Saavedra AS, Mensebach C, Wingenfeld K, Driessen M (2005)
Psychoneuroendocrinology 30(9): 919-923.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Lange, Wolfgang; Wulff, Hella; Berea, Christina; Beblo, Thomas; Saavedra, Anamaria Silva; Mensebach, Christoph; Wingenfeld, Katja; Driessen, MartinUniBi
Abstract / Bemerkung
Background Divergent findings of hypothalamic-pituitary-adrenal (HPA) axis functioning in borderline personality disorder (BPD) may be caused by a different degree of comorbid posttraumatic stress disorder (PTSD), in which alterations of the HPA axis are well known. Here we investigate alterations of the HPA axis in BPD patients with and without comorbid PTSD compared to healthy controls. Considering previous findings current major depression (MDD) was taken into account as a confounding variable. Methods Apart from clinical assessment the 0.5 mg dexamethasone suppression test (DST) was performed in 21 female borderline patients and 23 healthy controls. Results Twelve BPD patients suffered from comorbid PTSD. Relative suppression (%) did not differ between healthy controls and the total BPD group, but BPD patients with comorbid PTSD showed increased suppression compared to those without. Comorbid MDD was not associated with suppression. Conclusions Our results do not indicate a dysfunction of the HPA axis in BPD. However, comorbid PTSD seems to be associated with a relative hypersuppression in the 0.5 mg DST.
Erscheinungsjahr
2005
Zeitschriftentitel
Psychoneuroendocrinology
Band
30
Ausgabe
9
Seite(n)
919-923
ISSN
03064530
Page URI
https://pub.uni-bielefeld.de/record/2963408

Zitieren

Lange W, Wulff H, Berea C, et al. Dexamethasone suppression test in borderline personality disorder—effects of posttraumatic stress disorder. Psychoneuroendocrinology. 2005;30(9):919-923.
Lange, W., Wulff, H., Berea, C., Beblo, T., Saavedra, A. S., Mensebach, C., Wingenfeld, K., et al. (2005). Dexamethasone suppression test in borderline personality disorder—effects of posttraumatic stress disorder. Psychoneuroendocrinology, 30(9), 919-923. https://doi.org/10.1016/j.psyneuen.2005.02.009
Lange, Wolfgang, Wulff, Hella, Berea, Christina, Beblo, Thomas, Saavedra, Anamaria Silva, Mensebach, Christoph, Wingenfeld, Katja, and Driessen, Martin. 2005. “Dexamethasone suppression test in borderline personality disorder—effects of posttraumatic stress disorder”. Psychoneuroendocrinology 30 (9): 919-923.
Lange, W., Wulff, H., Berea, C., Beblo, T., Saavedra, A. S., Mensebach, C., Wingenfeld, K., and Driessen, M. (2005). Dexamethasone suppression test in borderline personality disorder—effects of posttraumatic stress disorder. Psychoneuroendocrinology 30, 919-923.
Lange, W., et al., 2005. Dexamethasone suppression test in borderline personality disorder—effects of posttraumatic stress disorder. Psychoneuroendocrinology, 30(9), p 919-923.
W. Lange, et al., “Dexamethasone suppression test in borderline personality disorder—effects of posttraumatic stress disorder”, Psychoneuroendocrinology, vol. 30, 2005, pp. 919-923.
Lange, W., Wulff, H., Berea, C., Beblo, T., Saavedra, A.S., Mensebach, C., Wingenfeld, K., Driessen, M.: Dexamethasone suppression test in borderline personality disorder—effects of posttraumatic stress disorder. Psychoneuroendocrinology. 30, 919-923 (2005).
Lange, Wolfgang, Wulff, Hella, Berea, Christina, Beblo, Thomas, Saavedra, Anamaria Silva, Mensebach, Christoph, Wingenfeld, Katja, and Driessen, Martin. “Dexamethasone suppression test in borderline personality disorder—effects of posttraumatic stress disorder”. Psychoneuroendocrinology 30.9 (2005): 919-923.

12 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Blunted neuroendocrine stress reactivity in young women with eating disorders.
Het S, Vocks S, Wolf JM, Hammelstein P, Herpertz S, Wolf OT., J Psychosom Res 78(3), 2015
PMID: 25499617
[Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
Tajima-Pozo K, Montes-Montero A, Guemes I, Gonzalez-Vives S, Diaz-Marsa M, Carrasco JL., Endocrinol Nutr 60(7), 2013
PMID: 23623464
The role of personality and traumatic events in cortisol levels--where does PTSD fit in?
Savic D, Knezevic G, Damjanovic S, Spiric Z, Matic G., Psychoneuroendocrinology 37(7), 2012
PMID: 22133516
Interconnection between biological abnormalities in borderline personality disorder: use of the Bayesian networks model.
De la Fuente JM, Bengoetxea E, Navarro F, Bobes J, Alarcon RD., Psychiatry Res 186(2-3), 2011
PMID: 20858567
Comorbidity of borderline personality disorder and posttraumatic stress disorder in the U.S. population.
Pagura J, Stein MB, Bolton JM, Cox BJ, Grant B, Sareen J., J Psychiatr Res 44(16), 2010
PMID: 20537660
Borderline personality disorder: hypothalamus pituitary adrenal axis and findings from neuroimaging studies.
Wingenfeld K, Spitzer C, Rullkotter N, Lowe B., Psychoneuroendocrinology 35(1), 2010
PMID: 19837517
Status of glucocorticoid alterations in post-traumatic stress disorder.
Yehuda R., Ann. N. Y. Acad. Sci. 1179(), 2009
PMID: 19906232
Cortisol response to interpersonal stress in young adults with borderline personality disorder: a pilot study.
Walter M, Bureau JF, Holmes BM, Bertha EA, Hollander M, Wheelis J, Brooks NH, Lyons-Ruth K., Eur. Psychiatry 23(3), 2008
PMID: 18325742
Enhanced cortisol suppression in eating disorders with impulsive personality features.
Diaz-Marsa M, Carrasco JL, Basurte E, Saiz J, Lopez-Ibor JJ, Hollander E., Psychiatry Res 158(1), 2008
PMID: 18182170
Stability of the dexamethasone suppression test in borderline personality disorder with and without comorbid PTSD: a one-year follow-up study.
Wingenfeld K, Lange W, Wulff H, Berea C, Beblo T, Saavedra AS, Mensebach C, Driessen M., J Clin Psychol 63(9), 2007
PMID: 17674401

18 References

Daten bereitgestellt von Europe PubMed Central.

Dexamethasone suppression test and Axis I diagnoses of inpatients with DSM-III borderline personality disorder.
Baxter L, Edell W, Gerner R, Fairbanks L, Gwirtsman H., J Clin Psychiatry 45(4), 1984
PMID: 6715286
[Enhanced suppression of cortisol after dexamethasone in borderline personality disorder. A pilot study]
Carrasco JL, Diaz-Marsa M, Ignacio Pastrana J, Molina R, Brotons L, Horcajadas C., Actas Esp Psiquiatr 31(3), 2003
PMID: 12772042
Basal cortisol, dexamethasone suppression of cortisol, and MHPG in adolescents after the 1988 earthquake in Armenia.
Goenjian AK, Yehuda R, Pynoos RS, Steinberg AM, Tashjian M, Yang RK, Najarian LM, Fairbanks LA., Am J Psychiatry 153(7), 1996
PMID: 8659616
Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression.
Grossman R, Yehuda R, New A, Schmeidler J, Silverman J, Mitropoulou V, Sta Maria N, Golier J, Siever L., Am J Psychiatry 160(7), 2003
PMID: 12832244
Cortisol secretion in endogenous depression. I. Basal plasma levels.
Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS., Arch. Gen. Psychiatry 42(9), 1985
PMID: 4037990

AUTHOR UNKNOWN, 0
EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder.
Lahmeyer HW, Val E, Gaviria FM, Prasad RB, Pandey GN, Rodgers P, Weiler MA, Altman EG., Psychiatry Res 25(1), 1988
PMID: 3217463
Erfassung von psychischen Belastungsfolgen: die impact of event Skala- revidierte Version (IES-R)
Maercker, Diagnostica 3(), 1998
DST studies in psychotic depression: a meta-analysis.
Nelson JC, Davis JM., Am J Psychiatry 154(11), 1997
PMID: 9356556
Urinary free cortisol excretion in elderly persons with minor and major depression.
Oldehinkel AJ, van den Berg MD, Flentge F, Bouhuys AL, ter Horst GJ, Ormel J., Psychiatry Res 104(1), 2001
PMID: 11600188

AUTHOR UNKNOWN, 0
Psychoneuroendocrinology of post-traumatic stress disorder.
Yehuda R., Psychiatr. Clin. North Am. 21(2), 1998
PMID: 9670231
Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder.
Yehuda R, Lowy MT, Southwick SM, Shaffer D, Giller EL Jr., Am J Psychiatry 148(4), 1991
PMID: 2006697
Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders.
Yehuda R, Boisoneau D, Mason JW, Giller EL., Biol. Psychiatry 34(1-2), 1993
PMID: 8373936
Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder.
Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW., Am J Psychiatry 150(1), 1993
PMID: 8417586
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 15896918
PubMed | Europe PMC

Suchen in

Google Scholar